TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690 CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.322 ARBOVIRAL INFECTIONS (INCLUDING, BUT NOT LIMITED TO, CHIKUNGUNYA FEVER, CALIFORNIA ENCEPHALITIS, ST. LOUIS ENCEPHALITIS, DENGUE FEVER AND WEST NILE VIRUS) (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN SEVEN DAYS)


 

Section 690.322  Arboviral Infections (Including, but Not Limited to, Chikungunya Fever, California Encephalitis, St. Louis Encephalitis, Dengue Fever and West Nile Virus) (Reportable by mail, telephone, facsimile or electronically as soon as possible, within seven days) 

 

a)         Control of Case

 

1)         Standard precautions shall be followed.

 

2)         Individuals suspected to have an arboviral infection shall have specimens (e.g., serum, cerebrospinal fluid (CSF)), as appropriate, collected and tested for arboviruses. For West Nile virus testing, specimens previously tested at commercial laboratories shall be sent to the Department for testing upon request of the Department.

 

b)         Control of Contacts 

No restrictions.

 

c)         General Measures 

Local health authorities shall inquire of all persons for whom a West Nile virus or other arbovirus test result is positive about recent blood donation. If a donation took place in the two weeks prior to onset of symptoms, the local health authority shall notify the director of the donation facility of the donor's name, date of birth, sex, zip code, state of residence, date of donation, date of illness onset, and arboviral test results. Patient information, including test results received by donation facilities, shall be confidential.

 

d)         Laboratory Reporting

 

1)         Laboratories shall report to the local health authority patients who have a positive result on any laboratory test indicative of and specific for detecting acute arboviral infection and any positive laboratory test indicative of and specific for detecting arboviral infection in a blood donor.

 

2)         Laboratories shall forward to the Department's laboratory clinical materials from patients who are suspected of having an acute arboviral infection or, upon request, clinical materials testing positive for arboviruses at any laboratory other than the Department's laboratory. Forwarding shall occur until otherwise directed each year.

 

(Source:  Amended at 38 Ill. Reg. 5533, effective February 11, 2014)